{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:36:10Z","timestamp":1760315770267,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":1449,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jjcc.2009.04.008","type":"journal-article","created":{"date-parts":[[2009,5,24]],"date-time":"2009-05-24T05:07:02Z","timestamp":1243141622000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study"],"prefix":"10.1016","volume":"54","author":[{"given":"Yuichiro","family":"Kashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuo","family":"Kumazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2009.04.008_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2009.04.008_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jjcc.2008.02.003","article-title":"Long-term effects of early statin therapy for patients with acute myocardial infarction treated with stent implantation","volume":"51","author":"Kadota","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2009.04.008_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jjcc.2008.08.008","article-title":"Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction","volume":"53","author":"Teshima","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2009.04.008_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1253\/circj.72.17","article-title":"Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID study","volume":"72","author":"Sato","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2009.04.008_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2005.11.031","article-title":"Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese","volume":"97","author":"Sakamoto","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2009.04.008_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2009.04.008_bib7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00005344-199312000-00012","article-title":"Influences of pravastatin and simvastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs","volume":"22","author":"Ichihara","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2009.04.008_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005344-200002000-00012","article-title":"Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs","volume":"35","author":"Satoh","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2009.04.008_bib9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1253\/circj.71.1348","article-title":"Usefulness of hydrophilic vs. lipophilic statins after acute myocardial infarction: subanalysis of MUSASHI-AMI","volume":"71","author":"Sakamoto","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2009.04.008_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000047060.60595.CC","article-title":"Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug\u2013drug interaction","volume":"107","author":"Lau","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2009.04.008_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.HYP.36.3.325","article-title":"Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells","volume":"36","author":"Ikeda","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2009.04.008_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(02)00194-6","article-title":"Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells","volume":"165","author":"Ito","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2009.04.008_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2009.04.008_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ahj.2004.11.023","article-title":"Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin versus Atorvastatin (VYVA) study.","volume":"149","author":"Ballantyne","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2009.04.008_bib15","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.clinthera.2004.11.016","volume":"26","author":"Bays","year":"2004","journal-title":"Clin Ther"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508709001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508709001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:46:42Z","timestamp":1760273202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508709001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0914508709001336"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2009.04.008","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2009.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}